Clinical Trials in Tennessee

Showing 15001-15020 of 20,239 trials

Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

NCT02129725

Our research proposal will determine if PDE-5 inhibition exerts a favorable effect on insulin signaling pathways in skeletal muscle of subjects with impaired fasting glucose and/or impaired glucose tolerance.

Metabolic Syndrome

Vanderbilt University Medical Center15 participantsStarted Apr 2014

Nashville, Tennessee, United States

TERMINATEDPhase 429 miles

Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis

NCT01409993

The purpose of this study is to determine the effect of chronic PDE5 inhibitor therapy on glucose metabolism in persons with prediabetes.

Impaired Glucose Tolerance

Vanderbilt University78 participantsStarted Aug 2011

Nashville, Tennessee, United States

COMPLETEDPhase 129 miles

Characteristics of Glargine in Type 2 Diabetics

NCT00574912

The study is to determine the dose response relationship of insulin glargine in type 2 diabetes over a 24-hour period and measuring the differences in glucose production among the differing doses of glargine. Hypothesis: Differing doses of insulin glargine over a 24-hour period in type 2 diabetes will show differing effects on endogenous glucose production, glucose disposal and carbohydrate and lipid flux.

Type 2 Diabetes

Vanderbilt University Medical Center20 participantsStarted Mar 2007

Nashville, Tennessee, United States

Effect of Prolonged PDE-5 Inhibition on Insulin Signaling in Skeletal Muscle.

Renin-Angiotensin and Fibrinolysis in Humans: Effect of Long-Term PDE5 Inhibition on Glucose Homeostasis

Characteristics of Glargine in Type 2 Diabetics

Find Trials by Condition in Tennessee

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

EXTEND (Eltrombopag Extended Dosing Study)

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Pilot Study of Tetomilast in Chronic Obstructive Pulmonary Disease (COPD) Associated With Emphysema

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Pediatric Schizophrenia Efficacy and Safety Study

AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis

Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension

Salivary Diagnostic Testing for IVF

Thiazolidinedione Intervention With Vitamin D Evaluation

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries

Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer